Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study

Documenti analoghi

• Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
  di: Anna Ossami Saidy, et al.
  Pubblicazione: (2025)
• Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy
  di: Gloria Iacoboni, et al.
  Pubblicazione: (2024)
• Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
  di: Mariana Bastos‐Oreiro, et al.
  Pubblicazione: (2025)
• Autologous stem cell transplantation in NK/T‐cell lymphoma: Prognostic impact of EBV‐DNA in a multinational cohort—A study by the EBMT Lymphoma Working Party
  di: Philipp Berning, et al.
  Pubblicazione: (2025)
• Mitochondrial retention in mature red blood cells from patients with sickle cell disease is associated with stress erythropoiesis but not with proinflammatory state
  di: Marc Romana, et al.
  Pubblicazione: (2024)